pozelimab
Drug Details
- Generic Name
- pozelimab
- Brand Names
- N/A
- Application Number
- Sponsor
- Catalent Indiana, LLC
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- N/A
- Active Ingredients
- POZELIMAB-BBFG
Indications and Usage
1 INDICATIONS AND USAGE VEOPOZ is indicated for the treatment of adult and pediatric patients 1 year of age and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease. VEOPOZ is a complement inhibitor indicated for the treatment of adult and pediatric patients 1 year of age and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease. ( 1 )